Table 1.
Total n = 2691 (%) |
Vaccinated n = 2143 (79.7%) |
Unvaccinated n = 546 (20.3%) |
|
---|---|---|---|
Male | 1101 (40.9) | 898 (81.7) | 201 (18.3) |
Female * | 1578 (58.6) | 1235 (78.3) | 343 (21.7) |
Age: mean (SD) | 62.5 (11.8) | 63.7 (11.5) | 58.0 (12.0) |
Age (years) | |||
18–49 | 396 (14.7) | 270 (68.2) | 126 (31.8) |
50–69 | 1444 (53.8) | 1113 (77.1) | 331 (22.9) |
≥70 | 847 (31.5) | 757 (89.5) | 89 (10.5) |
Highest level of education ** | |||
No formal/primary school | 72 (2.7) | 52 (72.2) | 20 (27.8) |
Secondary school | 921 (34.3) | 726 (78.8) | 195 (21.2) |
Vocational/Trade | 679 (25.2) | 526 (77.5) | 153 (22.5) |
University | 1009 (37.5) | 834 (82.7) | 175 (17.3) |
Annual household income (AUD) | |||
<50 K | 898 (33.4) | 694 (77.3) | 204 (22.7) |
50 K–100 K | 653 (24.3) | 543 (83.2) | 110 (16.8) |
100 K–150 K | 364 (13.5) | 286 (78.6) | 78 (21.4) |
>150 K | 307 (11.4) | 269 (87.6) | 38 (12.4) |
Prefer not to say | 467 (17.4) | 351 (75.2) | 116 (24.8) |
Aboriginal/Torres Strait Islander *** | |||
Yes | 38 (1.4) | 32 (84.2) | 6 (15.8) |
English as dominant language | |||
Yes | 2429 (90.3) | 1963 (80.9) | 464 (19.1) |
No | 261 (9.7) | 180 (69.0) | 81 (31.0) |
Location | |||
Metropolitan | 1918 (71.3) | 1594 (83.1) | 324 (16.9) |
Regional/rural | 773 (28.7) | 549 (71.2) | 222 (22.8) |
Cancer type | |||
Breast | 986 (36.6) | 807 (81.8) | 179 (18.2) |
Genitourinary | 501 (18.6) | 424 (84.8) | 76 (15.2) |
Gastrointestinal | 493 (18.3) | 375 (76.1) | 118 (23.9) |
Lung | 248 (9.2) | 194 (78.2) | 54 (21.8) |
Skin | 151 (5.6) | 123 (82.0) | 27 (18.0) |
Gynecological | 134 (5.0) | 91 (67.9) | 43 (32.1) |
Head and Neck | 99 (3.7) | 69 (69.1) | 30 (30.3) |
Other | 79 (2.9) | 60 (75.9) | 19 (24.1) |
Cancer stage | |||
Localized | 1593 (59.2) | 1291 (81.1) | 301 (18.9) |
Metastatic | 971 (36.1) | 770 (79.4) | 200 (20.6) |
Unsure/Other | 127 (4.7) | 82 (64.6) | 45 (35.4) |
Time since diagnosis | |||
<6 months | 372 (13.8) | 251 (67.5) | 121 (32.5) |
6–24 months | 964 (35.8) | 755 (78.4) | 208 (21.6) |
2–5 years | 841 (31.3) | 695 (82.6) | 146 (17.4) |
>5 years | 514 (19.1) | 442 (86.2) | 71 (13.8) |
Current anti-cancer treatment | |||
Yes | 1506 (56.0) | 1181 (78.5) | 323 (21.5) |
No | 1185 (44.0) | 962 (81.2) | 223 (18.8) |
Notes: exact cohort for vaccination status n = 2689. * does not include “non-binary/prefer not to say” n = 12 (0.4%), ** Other: 8 (0.3%); *** does not include “prefer not to say” n = 27 (1.0%). Abbreviations: AUD, Australian dollars; K, 1000.